Plasma low-molecular weight fluorescence in type 1 diabetes mellitus

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 655-661

  Januszewski, A S ^a   Thomas, M C ^b   Chung, S J ^a   Karschimkus, C S ^a   Rowley, K G ^a   Nelson, C ^a   O'Neal, D ^a   Wang, Z ^a   Best, J D ^a   Jenkins, Alicia J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Advanced glycation end products; Fluorophores; Renal function; Type 1 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; BIOACCUMULATION; BLOOD SAMPLING; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE MARKER; EXPERIMENTAL MODEL; FEMALE; FLUORESCENCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; OXIDATIVE STRESS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 23744470200     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1333.074     Document Type: Conference Paper

References (16)

1. JENKINS, A.J., J.D. BEST, R.L. KLEIN & T.J. LYONS. 2004. Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metab. Res. Rev. 20: 349-368.
2. KUNT, T., T. FORST, O. HARZER, et al. 1998. The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules. Exp. Clin. Endocrinol. Diabetes 106: 183-188.
3. BASTA, G., A.M. SCHMIDT & R. DE CATERINA. 2004. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 63: 582-592.
4. MIURA, J., S. YAMAGISHI, Y. UCHIGATA, et al. 2003. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes. J. Diabetes Complications 17: 16-21.
5. e-(carboxymethyl)lysine ELISA. Diabetes Care 26: 2609-2615.
6. MAKITA, Z., S. RADOFF, E.J. RAYFIELD, et al. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325: 836-842.
7. SHARP, P.S., S. RAINBOW & S. MUKHERJEE. 2003. Serum levels of low molecular weight advanced glycation end products in diabetic subjects. Diabet. Med. 20: 575-579.
8. THOMAS, M.C., C. TSALAMANDRIS, R. MACISAAC, et al. 2004. Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int. 66: 1167-1172.
9. WROBEL, K., K. WROBEL, M.E. GARAY-SEVILLA, et al. 1997. Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin. Chem. 43: 1563-1569.
10. TAN, K.C., W.S. CHOW, V.H. AI, et al. 2002. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care 25: 1055-1059.
11. GUGLIUCCI, A. & M. BENDAYAN. 1996. Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39: 149-160.
12. MAKITA, Z., R. BUCALA, E.J. RAYFIELD, et al. 1994. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343: 1519-1522.
13. GERDEMANN, A., H.D. LEMKE, A. NOTHDURFT, et al. 2000. Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis. Clin. Nephrol. 54: 276-283.
14. JANUSZEWSKI, A.S., N.L. ALDERSON, T.O. METZ, et al. 2003. Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem. Soc. Trans. 31: 1413-1416.
15. VLASSARA, H., H. FUH, Z. MAKITA, et al. 1992. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. USA 89: 12043-12047.
16. FORBES, J.M., M.E. COOPER, V. THALLAS, et al. 2002. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51: 3274-3282.